• bitcoinBitcoin(BTC)$83,325.00-1.88%
  • ethereumEthereum(ETH)$2,679.02-0.89%
  • tetherTether(USDT)$1.00-0.01%
  • binancecoinBNB(BNB)$762.79-2.13%
  • rippleXRP(XRP)$1.50-1.83%
  • usd-coinUSDC(USDC)$1.00-0.01%
  • solanaSolana(SOL)$118.98-3.01%
  • tronTRON(TRX)$0.3346710.37%
  • zcashZcash(ZEC)$1,577.72-3.70%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.060.00%
  • HyperliquidHyperliquid(HYPE)$88.63-3.63%
  • dogecoinDogecoin(DOGE)$0.093058-4.56%
  • chainlinkChainlink(LINK)$14.412.22%
  • moneroMonero(XMR)$528.81-3.40%
  • whitebitWhiteBIT Coin(WBT)$83.31-1.59%
  • USDSUSDS(USDS)$1.00-0.03%
  • cardanoCardano(ADA)$0.245610-3.79%
  • RainRain(RAIN)$0.012563-0.49%
  • leo-tokenLEO Token(LEO)$9.00-0.25%
  • stellarStellar(XLM)$0.2182421.00%
  • nearNEAR Protocol(NEAR)$5.14-1.60%
  • bitcoin-cashBitcoin Cash(BCH)$311.16-7.18%
  • uniswapUniswap(UNI)$8.90-9.42%
  • litecoinLitecoin(LTC)$69.81-1.77%
  • CantonCanton(CC)$0.131513-2.17%
  • hedera-hashgraphHedera(HBAR)$0.11858926.36%
  • Ethena USDeEthena USDe(USDE)$1.000.01%
  • avalanche-2Avalanche(AVAX)$10.38-5.30%
  • suiSui(SUI)$1.17-6.08%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.653.94%
  • daiDai(DAI)$1.000.03%
  • USD1USD1(USD1)$1.00-0.01%
  • BitwayBitway(BTW)$1.3718.81%
  • BittensorBittensor(TAO)$303.18-7.12%
  • crypto-com-chainCronos(CRO)$0.0682871.02%
  • quant-networkQuant(QNT)$230.7341.35%
  • shiba-inuShiba Inu(SHIB)$0.000006-4.62%
  • Global DollarGlobal Dollar(USDG)$1.000.02%
  • tether-goldTether Gold(XAUT)$4,144.51-3.14%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.02%
  • EthenaEthena(ENA)$0.264822-2.08%
  • MemeCoreMemeCore(M)$1.17-2.86%
  • OndoOndo(ONDO)$0.52-4.86%
  • Ripple USDRipple USD(RLUSD)$1.000.02%
  • okbOKB(OKB)$118.20-2.96%
  • Pump.funPump.fun(PUMP)$0.0051918.93%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • aaveAave(AAVE)$147.69-4.32%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.150.29%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Ex-McKinsey partner sentenced to 6 months in prison for obstructing probes into opioid crisis

May 23, 2025
in Business
Reading Time: 3 mins read
A A
Ex-McKinsey partner sentenced to 6 months in prison for obstructing probes into opioid crisis
ShareShareShareShareShare

A former senior partner at McKinsey & Company was sentenced on Friday to six months in federal prison for destroying records of the firm’s work to “turbocharge” Purdue Pharma’s OxyContin sales during the opioid crisis.

YOU MAY ALSO LIKE

Email spam filters cost GOP fundraisers estimated $117M in donations last year: bombshell study

Solidcore signs deal for Upper East Side location

Martin Elling, 60, pleaded guilty in January to obstruction of justice related to criminal investigations into McKinsey’s consulting work with opioid manufacturers. McKinsey last year agreed to pay $650 million to settle those probes.

“Today’s sentencing sends a resounding message: those who attempt to obstruct justice and conceal the truth – no matter how senior, sophisticated, or well-connected – will be held accountable,” Leah Foley, US Attorney for the District of Massachusetts, said in a statement.

Martin Elling, a former senior partner at McKinsey & Company. McKinsey & Company

In a statement, Elling’s legal team confirmed the sentencing and said he is “extremely sorry.”

“He intends to spend the remainder of his life seeking to regain the trust of those whom he disappointed with his conduct, by supporting his family and friends and giving back to the less fortunate, as he has done for the past decades,” his lawyers told The Post.

Elling’s sentencing took place at a federal courthouse in Abingdon, Va., a town in Appalachia – one of the regions hit hardest by the opioid crisis, which killed more than 42,000 people across the country in 2016 alone, according to the National Library of Medicine.

Purdue Pharma engaged McKinsey in 2013 to drive OxyContin revenue and “turbocharge” sales, according to court documents.

Elling, who was also ordered to perform 1,000 hours of community service and pay a $40,000 fine, served as the director of the team for about 30 of McKinsey’s engagements with the pharma giant, according to the Department of Justice.

In 2018, Elling emailed another senior partner with concerns that a Purdue board member was being sued by state attorneys general.

“It probably makes sense to have a quick conversation with the risk committee to see if we should be doing anything other [than] eliminating all our documents and emails. Suspect not but as things get tougher there someone might turn to us,” Elling wrote.

Purdue Pharma reportedly engaged McKinsey & Company to “turbocharge” OxyContin sales. REUTERS

A forensic analysis found that Elling had deleted materials from his company-issued laptop related to their work with Purdue – after seemingly emailing himself a reminder.

The subject line of a 2018 email to himself read “When home,” and the items listed included: “deleted old pur documents from laptop,” according to court documents.

He later emailed himself another reminder: “Remove Pur folder from garbage,” according to the analysis.

Elling was fired from McKinsey in 2020. 

The consulting firm in December apologized for its work with Purdue and “the actions of a former partner who deleted documents related to his work for that client.”

McKinsey & Company agreed to pay $650 million to settle investigations into its work with opioid manufacturers. REUTERS

Prosecutors had asked the judge to sentence Elling to a year in prison.

“This is a rare case: a well-educated senior partner at one of the world’s foremost consulting companies was caught destroying documents relating to the investigation of OxyContin, a powerful opioid narcotic drug, against the tragic backdrop of the opioid crisis,” prosecutors said in a memo signed by Randy Ramseyer.

Ramseyer led a probe into Purdue in 2007 that secured guilty pleas from its executives for misleading doctors and patients about OxyContin risks.

McKinsey, one of the most prestigious consulting firms in the world, employs more than 700 senior partners who are typically paid millions of dollars a year.

Credit: Source link

ShareTweetSendSharePin

Related Posts

Email spam filters cost GOP fundraisers estimated 7M in donations last year: bombshell study
Business

Email spam filters cost GOP fundraisers estimated $117M in donations last year: bombshell study

September 28, 2026
Solidcore signs deal for Upper East Side location
Business

Solidcore signs deal for Upper East Side location

September 27, 2026
Stephen Ross expanding in Boca Raton at a 124-acre, former IBM facility
Business

Stephen Ross expanding in Boca Raton at a 124-acre, former IBM facility

September 27, 2026
Times Square may score another Asian entertainment lease
Business

Times Square may score another Asian entertainment lease

September 27, 2026
Next Post
Trump says U.S. will lift all sanctions on Syria

Trump says U.S. will lift all sanctions on Syria

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Hand And Eye Tracking Is So Much Better Than A Controller

Hand And Eye Tracking Is So Much Better Than A Controller

September 24, 2026
Should You Short The Market Right Now?

Should You Short The Market Right Now?

September 25, 2026
Dozens of attacks reported across southern Thailand

Dozens of attacks reported across southern Thailand

September 25, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!